Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
It belongs to a class of drugs called ACE inhibitors
However, chronic stress can exhaust the adrenals, making it difficult to maintain proper function
Pittman filed his legal reasoning under seal, but by denying the injunction request, a May timeline set by the FDA for when large U.S
C and S64